430 related articles for article (PubMed ID: 16782234)
1. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
Zipser BD; Johanson CE; Gonzalez L; Berzin TM; Tavares R; Hulette CM; Vitek MP; Hovanesian V; Stopa EG
Neurobiol Aging; 2007 Jul; 28(7):977-86. PubMed ID: 16782234
[TBL] [Abstract][Full Text] [Related]
2. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
[TBL] [Abstract][Full Text] [Related]
3. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
[TBL] [Abstract][Full Text] [Related]
4. The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype.
Trembath D; Ervin JF; Broom L; Szymanski M; Welsh-Bohmer K; Pieper C; Hulette CM
Acta Neuropathol; 2007 Jan; 113(1):23-31. PubMed ID: 17089130
[TBL] [Abstract][Full Text] [Related]
5. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
Merlini M; Wanner D; Nitsch RM
Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
van Helmond ZK; Miners JS; Bednall E; Chalmers KA; Zhang Y; Wilcock GK; Love S; Kehoe PG
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):317-27. PubMed ID: 17493012
[TBL] [Abstract][Full Text] [Related]
7. Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen.
Tian J; Shi J; Smallman R; Iwatsubo T; Mann DM
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):332-40. PubMed ID: 16640651
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
Dement Geriatr Cogn Disord; 2007; 23(4):241-5. PubMed ID: 17310121
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
Donahue JE; Johanson CE
J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
[TBL] [Abstract][Full Text] [Related]
10. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
11. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
12. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
[TBL] [Abstract][Full Text] [Related]
13. Elevated cortical zinc in Alzheimer disease.
Religa D; Strozyk D; Cherny RA; Volitakis I; Haroutunian V; Winblad B; Naslund J; Bush AI
Neurology; 2006 Jul; 67(1):69-75. PubMed ID: 16832080
[TBL] [Abstract][Full Text] [Related]
14. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study.
Jellinger KA; Attems J
Acta Neuropathol; 2003 Jan; 105(1):14-7. PubMed ID: 12471455
[TBL] [Abstract][Full Text] [Related]
15. Localization of amyloid P component in human brain: vascular staining patterns and association with Alzheimer's disease lesions.
Perlmutter LS; Barrón E; Myers M; Saperia D; Chui HC
J Comp Neurol; 1995 Jan; 352(1):92-105. PubMed ID: 7714241
[TBL] [Abstract][Full Text] [Related]
16. Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease.
Salloway S; Gur T; Berzin T; Tavares R; Zipser B; Correia S; Hovanesian V; Fallon J; Kuo-Leblanc V; Glass D; Hulette C; Rosenberg C; Vitek M; Stopa E
J Neurol Sci; 2002 Nov; 203-204():183-7. PubMed ID: 12417381
[TBL] [Abstract][Full Text] [Related]
17. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
Jellinger KA; Attems J
Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
[TBL] [Abstract][Full Text] [Related]
19. Aquaporin expression in the cerebral cortex is increased at early stages of Alzheimer disease.
Pérez E; Barrachina M; Rodríguez A; Torrejón-Escribano B; Boada M; Hernández I; Sánchez M; Ferrer I
Brain Res; 2007 Jan; 1128(1):164-74. PubMed ID: 17123487
[TBL] [Abstract][Full Text] [Related]
20. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
Jeynes B; Provias J
Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
